Strides Shasun receives USFDA approval for Promethazine Hydrochloride Tablets

03 Jul 2017 Evaluate

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Promethazine Hydrochloride Tablets USP, 12.5 mg, 25 mg, and 50 mg. Promethazine Hydrochloride Tablet is used to prevent and treat nausea and vomiting related to certain conditions. It is also used to treat allergy symptoms such as rash, itching, and runny nose.

The product will be manufactured at the company’s flagship facility at Bangalore and marketed by Strides Pharma Inc. in the US Market. According to IMS data, the US market for Promethazine Hydrochloride Tablets USP, 12.5 mg, 25 mg, and 50 mg is approximately $17 million.

Strides Shasun is a vertically integrated global pharmaceutical Company headquartered in Bangalore. The company has four business verticals, viz., Regulated Markets, Emerging Markets, Institutional Business and Active Pharmaceutical Ingredients.


Strides Pharma Scien Share Price

806.70 10.50 (1.32%)
29-Jan-2026 13:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1596.05
Dr. Reddys Lab 1198.50
Cipla 1317.50
Zydus Lifesciences 887.00
Lupin 2118.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×